D S McKinsey

Summary

Affiliation: St. John's Mercy Medical Center
Country: USA

Publications

  1. ncbi request reprint Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group
    D S McKinsey
    University of Missouri Kansas City School of Medicine, and Kansas City AIDS Research Consortium, USA
    Clin Infect Dis 28:1049-56. 1999

Detail Information

Publications1

  1. ncbi request reprint Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group
    D S McKinsey
    University of Missouri Kansas City School of Medicine, and Kansas City AIDS Research Consortium, USA
    Clin Infect Dis 28:1049-56. 1999
    ..A survival benefit was not demonstrated. Itraconazole generally was well tolerated. Primary prophylaxis with itraconazole capsules prevents histoplasmosis and cryptococcosis in patients with HIV infection...